Cellular elements of the subarachnoid space promote ALL survival during chemotherapy.
CNS infiltration by leukemic cells remains a problematic disease manifestation of acute lymphoblastic leukemia (ALL). Prophylactic regimens for CNS leukemia including intrathecal chemotherapeutics have decreased CNS involvement in ALL, but are not without toxicities. Using co-culture models, we show that astrocytes, choroid plexus epithelial cells, and meningeal cells protect ALL cells from chemotherapy-induced cell death using drugs included in prophylactic regimens-cytarabine, dexamethasone, and methotrexate. Understanding how ALL cells survive in the CNS remains invaluable for designing strategies to prevent CNS leukemia and minimizing the need for treatment in this sensitive anatomical site where treatment-induced toxicity is of significant concern.
Cancer Cell Biology Program, Robert C. Byrd Health Sciences Center, West Virginia University, School of Medicine, Morgantown, WV, USA.
Stephen M
SM
Akers
Stephanie L
SL
Rellick
James E
JE
Fortney
Laura F
LF
Gibson
D000970:Antineoplastic Agents / Q000494:pharmacology; D001253:Astrocytes / Q000166:cytology / Q000187:drug effects; D002450:Cell Communication / Q000187:drug effects; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D002831:Choroid Plexus / Q000166:cytology; D018920:Coculture Techniques; D003561:Cytarabine / Q000494:pharmacology*; D003907:Dexamethasone / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects; D006801:Humans; D008578:Meninges / Q000166:cytology; D008727:Methotrexate / Q000494:pharmacology*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000473:pathology; D013346:Subarachnoid Space / Q000187:drug effects / Q000473:pathology; D013997:Time Factors
D000970:Antineoplastic Agents; D003561:Cytarabine; D003907:Dexamethasone; D008727:Methotrexate
Acta Neurobiol Exp (Wars). 2006;66(4):343-58
17265695
Hematol Oncol Clin North Am. 2001 Feb;15(1):145-62
11253605
Cell Tissue Res. 1999 May;296(2):259-69
10382270
Trends Neurosci. 2003 Oct;26(10):523-30
14522144
Exp Hematol. 2009 Nov;37(11):1295-309
19716854
Br J Haematol. 2009 May;145(4):491-9
19344405
Leuk Lymphoma. 2002 Jan;43(1):19-27
11908727
Cancer. 2010 May 15;116(10):2290-300
20209620
Leukemia. 2010 Feb;24(2):371-82
20010620
J Neuropathol Exp Neurol. 2000 Jul;59(7):561-74
10901227
Semin Oncol. 2009 Aug;36(4 Suppl 2):S2-S16
19660680
Dev Biol. 1999 Sep 15;213(2):442-56
10479460
Cancer Res. 2007 May 1;67(9):4482-90
17483364
Ann Neurol. 2006 Jun;59(6):880-92
16718690
Exp Hematol. 2001 Dec;29(12):1439-47
11750103
N Engl J Med. 2009 Jun 25;360(26):2730-41
19553647
J Immunol. 2008 Sep 1;181(5):3027-38
18713973
Cancer Lett. 2004 Apr 30;207(2):229-39
15072833
J Immunol. 1995 Feb 15;154(4):1888-99
7530745
J Immunol. 2009 Apr 15;182(8):4705-12
19342646
Clin Cancer Res. 2008 May 1;14(9):2519-26
18451212
Trends Immunol. 2005 May;26(5):254-9
15866238
Hematology Am Soc Hematol Educ Program. 2006;:142-6
17124053
Nat Rev Immunol. 2003 Jul;3(7):569-81
12876559